4//SEC Filing
Poddar Richa 4
Accession 0001439222-22-000010
CIK 0001439222other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:00 PM ET
Size
8.3 KB
Accession
0001439222-22-000010
Insider Transaction Report
Form 4
Poddar Richa
Chief Commercial Officer
Transactions
- Tax Payment
Common stock
2022-02-14$30.50/sh−590$17,995→ 2,641 total - Exercise/Conversion
Common stock
2022-02-14+1,738→ 3,231 total - Exercise/Conversion
Restricted stock units
2022-02-14−1,738→ 1,738 total→ Common stock (1,738 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001897274
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:00 PM ET
- Size
- 8.3 KB